American Society of Hirudotherapy

Salivary transcriptome of the North American medicinal leech, Macrobdella decora

Min GS, Sarkar IN, Siddall ME (2010) · Journal of Parasitology

Preclinical / molecular study: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Model / material
expressed sequence tag (EST) library-based analysis of the salivary transcriptome of the North American medicinal leech Macrobdella decora (Department of Biological Sciences, Inha University, Korea; with US co-authors)
Method
EST library construction and sequence-homology-based identification of bioactive salivary transcripts in M. decora; phylogenetic comparison with European/Asian Hirudo species and other sanguivorous annelids
Main result
M. decora salivary transcriptome contains transcripts corresponding to saratin, bdellin, destabilase, hirudin, decorsin, endoglucoronidase, antistatin, eglin, as well as previously uncharacterized serine protease inhibitors, lectoxin-like c-type lectins, ficolin, disintegrins, and histidine-rich proteins; the comprehensive richness of bioactive polypeptides supports the long-recognized clinical analgesic and anticoagulant effects of sanguivorous leeches; molecular phylogeny provides preliminary evaluation of evolutionary origins and historical conservation of leech salivary components

Key Findings

  • First comprehensive salivary transcriptome of the North American medicinal leech, Macrobdella decora
  • Confirms presence of canonical leech salivary bioactive families (hirudin, decorsin, antistatin, eglin, bdellin, destabilase) in a North American species
  • Identifies novel transcript classes including lectoxin-like c-type lectins, ficolin, disintegrins, and histidine-rich proteins
  • Supports the case that leech-salivary bioactive diversity is conserved across geographically distant sanguivorous leech species
  • Provides phylogenetic framework for understanding evolutionary origins of leech salivary pharmacology

Limitations

  • EST library-based approach has lower sensitivity and depth than modern RNA-Seq
  • Sequence-homology-based annotation rather than direct functional characterization
  • No in vivo or in vitro pharmacology data on M. decora salivary components
  • Single-species transcriptome - cross-species comparison limited to homology-based inference
  • North American medicinal leech (M. decora) not currently used commercially in the US under K040187

Clinical Implications

Min 2010 documents that the North American medicinal leech (Macrobdella decora) contains the same canonical bioactive families found in European/Asian medicinal leeches, providing evolutionary support for the broad applicability of leech salivary pharmacology. For ASH editorial purposes, the trial is essential context for understanding the cross-species conservation of leech-derived therapeutic molecules. For US clinicians and research-focused readers, the trial provides important geographic context: the M. decora species native to North America has not been developed for commercial therapy (which uses imported H. verbana) but represents a potential indigenous resource for future leech-derived pharmaceutical development.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.